Why the study?
Although MI treatment has improved, morbidity and mortality remain high, and discovering ideal treatments committed to cardioprotection and cardiac repair after ischemia remains an ongoing challenge.
Design
Review
Authors
Loading...
Signaling-targeted MI therapies remain investigational; leaves open the need for randomized trials to establish clinical efficacy.
Key points are not available for this paper at this time.
Zhang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: